RAC 0.93% $1.62 race oncology ltd

[INTERVIEW] Breaking Barriers in Cancer Treatment: Race Oncology Pioneers a New Era with Bisantrene, page-46

  1. 2,676 Posts.
    lightbulb Created with Sketch. 10277
    You might want to look again at the investor presentation we put out in November - slide 33 to be exact.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.